By Professor Jeff Holst

Conference Abstracts

Persson ML; Jackson ER; Duchatel RJ; de la Nava D; Thomas BC; Savary C; Mcewen HP; Beitaki TS; Kearney PS; Findlay IJ; Douglas AM; Larsen MR; Faridi P; Holst J; Mayall J; Hondermarck H; Horvat J; Nixon B; Cartaxo RT; Nazarian J; Hulleman E; Mueller S; Vitanza NA; Koshmann C; Alonso MM; Carvalheiro T; van der Lugt J; Dun MD, 2024, 'DRD2 ANTAGONISM RESCUES IMMUNE-TUMOR SURVEILLANCE, WARMING THE TUMOR IMMUNE MICROENVIRONMENT OF DIFFUSE MIDLINE GLIOMA MODELS', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, PA, Philadelphia, Vol. 26, presented at International Symposium on Pediatric Neuro-Oncology (ISPNO), PA, Philadelphia, 29 June 2024 - 02 July 2024, http://dx.doi.org/10.1093/neuonc/noae064.089

Wahi K; Freidman N; Wang Q; Guan YF; Holst J, 2023, 'Macropinocytosis mediates metabolic resistance to loss of glutamine transport in triple-negative breast cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 84, presented at AACR Special Conference on Cancer Research - Advances in Breast Cancer Research, CA, San Diego, 19 October 2023 - 22 October 2023, http://dx.doi.org/10.1158/1538-7445.ADVBC23-A036

Zhao X; Zhang YY; Xu L; La T; Feng YC; Tang HJ; Xu R; Narayana VK; De Souza DP; Quek L-E; Holst J; Thorne RF; Baker M; Liu T; Jin L; Zhang XD, 2023, 'Abstract 3687: Disruption of nucleotide homeostasis confers cancer cell susceptibility to oxidative phosphorylation inhibition independently of energy depletion', in Cancer Research, American Association for Cancer Research (AACR), Vol. 83, pp. 3687 - 3687, http://dx.doi.org/10.1158/1538-7445.am2023-3687

Persson M; Jackson E; Duchatel R; Bramberger L; McEwen H; Kearney P; Findlay I; Douglas A; Kobbe B; Wagener R; Larsen M; Faridi P; Holst J; Mayall J; Gedye C; Hondermarck H; Horvat J; Nixon B; Cartaxo R; Koschmann C; Valdes-Mora F; Ortega DG; Nazarian J; Alonso MM; Hulleman E; Van der Lugt J; Vitanza N; Mueller S; Dun M, 2022, 'TMIC-06. ANTAGONISM OF DRD2 USING ONC201 INCREASED EXPRESSION OF ANTIGEN PRESENTATION PATHWAY PROTEINS IN DIFFUSE MIDLINE GLIOMA, RECRUITING TUMOR INFILTRATING LYMPHOCYTES IN VIVO', in Neuro-Oncology, Oxford University Press (OUP), Vol. 24, pp. vii272 - vii272, http://dx.doi.org/10.1093/neuonc/noac209.1050

Mandigo AC; McNair C; Ku K; Pang A; Guan YF; Holst J; Brown M; Kelly WK; Knudsen KE, 2020, 'Molecular underpinnings of RB status as a biomarker of poor outcome in advanced prostate cancer.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 38, pp. 189 - 189, http://dx.doi.org/10.1200/jco.2020.38.6_suppl.189

Mandigo AC; McNair C; Ku K; Pang A; Guan YF; Holst J; Brown M; Kelly WK; Knudsen KE, 2020, 'Molecular underpinnings of RB status as a biomarker of poor outcome in advanced prostate cancer', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 38, presented at Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), CA, San Francisco, 13 February 2020 - 15 February 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000529525900258&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

van Geldermalsen M; Quek L-E; Turner N; Balaban S; Hoy A; Pang A; Guan YF; Wahi K; Wang Q; Holst J, 2019, 'Vulnerabilities in glutamine metabolism define triple-negative from Luminal A breast cancer subsets', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, TX, San Antonio, Vol. 80, presented at 42nd Annual San Antonio Breast Cancer Symposium, TX, San Antonio, 09 December 2019 - 14 December 2019, http://dx.doi.org/10.1158/1538-7445.SABCS19-P3-02-09

Akerman A; Sharbeen G; Holst J; Youkhana J; McCarroll J; Goldstein D; Erkan M; Phillips P, 2018, 'Targeting a solute carrier to metabolically reprogram tumour-promoting stromal cells in pancreatic cancer', in Pancreatology, Elsevier BV, Vol. 18, pp. S156 - S156, http://dx.doi.org/10.1016/j.pan.2018.05.419

van Geldermalsen M; Wang Q; Bailey CG; Feng Y; Nagarajah R; Marshall A; Thoeng A; O'Toole S; Rasko JEJ; Holst J, 2015, 'Targeting the ASCT2 glutamine uptake and metabolism pathway in triple-negative breast cancer', in Annals of Oncology, Vol. 26, pp. iii31, http://dx.doi.org/10.1093/annonc/mdv121.04

Colas C; Grewer C; Gameiro A; Albers T; Singh K; Otte NJ; Shere H; Massimiliano B; Holst J; Schlessinger A, 2015, 'Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening', in BIOPHYSICAL JOURNAL, CELL PRESS, Vol. 108, pp. 54A - 54A, http://dx.doi.org/10.1016/j.bpj.2014.11.329

Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minnas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JEJ; Holst J, 2012, 'Androgen receptor and nutrient signaling pathways coordinate increased amino acid transport in prostate cancer progression', in BMC proceedings, Vol. 6, pp. P23 - P23, http://dx.doi.org/10.1186/1753-6561-6-s3-p23

Ardjmand A; Bock CED; Molloy TJ; Bone SM; Johnstone D; Campbell DM; Shipman KL; Yeadon TM; Holst J; Spanevello MD; Catchpoole DR; Lincz LF; Boyd AW; Burns GF; Thorne RF, 2011, 'Altered expression of Fat1 cadherin, a novel tumor marker for acute lymphoblastic leukemia', in Clinical Biochemistry, Elsevier BV, Vol. 44, pp. S71 - S71, http://dx.doi.org/10.1016/j.clinbiochem.2011.08.154

Tiffen JC; Bailey CG; Ng C; Watson SL; Loukinov DI; Lobanenkov VV; Holst J; Rasko JEJ, 2010, 'BORIS and its paralogue CTCF exhibit similar biological functions', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, NORWAY, Oslo, Vol. 8, pp. 176 - 177, presented at 21st Meeting of the European-Association-for-Cancer-Research, NORWAY, Oslo, 26 June 2010 - 29 June 2010, http://dx.doi.org/10.1016/S1359-6349(10)71497-X

Back to profile page